Forte Biosciences, Inc. $FBRX Stake Boosted by AlphaQuest LLC

Core Insights - AlphaQuest LLC increased its stake in Forte Biosciences by 300.7% in Q2, owning 16,897 shares valued at $218,000 [2] - Analysts have mixed ratings on Forte Biosciences, with a consensus rating of "Moderate Buy" and an average price target of $68.00 [3] - Forte Biosciences reported an EPS of ($0.96) for the last quarter, exceeding the consensus estimate of ($1.21) by $0.25 [5] Company Overview - Forte Biosciences is a biopharmaceutical company based in Dallas, Texas, focusing on developing treatments for autoimmune diseases [6] - The company is working on the FB-102 program, targeting conditions such as graft-versus-host disease, vitiligo, and alopecia areata [6] Stock Performance - Forte Biosciences shares opened at $12.94, with a market capitalization of $160.84 million and a P/E ratio of -1.88 [4] - The stock has experienced a 12-month low of $4.11 and a high of $28.68 [4]